- Home
- MELI vs BMY Comparison
MELI vs BMY Comparison
Compare MELI & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MELI | BMY |
|---|---|---|
| Founded | 1999 | 1887 |
| Country | Uruguay | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 103.8B | 95.0B |
| IPO Year | 2007 | N/A |
Fundamental Metrics
Financial Performance| Metric | MELI | BMY |
|---|---|---|
| Price | $2,024.01 | $52.72 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 18 | 11 |
| Target Price | ★ $2,873.89 | $55.09 |
| AVG Volume (30 Days) | 571.2K | ★ 14.9M |
| Earning Date | 10-29-2025 | 10-30-2025 |
| Dividend Yield | N/A | ★ 4.84% |
| EPS Growth | ★ 45.68 | N/A |
| EPS | ★ 40.97 | 2.97 |
| Revenue | $26,193,000,000.00 | ★ $48,034,000,000.00 |
| Revenue This Year | $40.30 | $0.23 |
| Revenue Next Year | $28.24 | N/A |
| P/E Ratio | $49.30 | ★ $17.24 |
| Revenue Growth | ★ 36.94 | 1.26 |
| 52 Week Low | $1,646.00 | $42.52 |
| 52 Week High | $2,645.22 | $63.33 |
Technical Indicators
Market Signals| Indicator | MELI | BMY |
|---|---|---|
| Relative Strength Index (RSI) | 43.69 | 69.21 |
| Support Level | $1,957.00 | $50.33 |
| Resistance Level | $2,163.00 | $52.51 |
| Average True Range (ATR) | 64.49 | 1.12 |
| MACD | 0.65 | 0.20 |
| Stochastic Oscillator | 36.47 | 94.46 |
Price Performance
Historical ComparisonAbout MELI MercadoLibre Inc.
MercadoLibre runs the largest e-commerce marketplace in Latin America, with more than 218 million active users and 1 million active sellers across 18 countries stitching into its commerce network or fintech solutions when last reported. The company operates a host of complementary businesses to its core online shop, with shipping solutions (Mercado Envios), a payment and financing operation (Mercado Pago and Mercado Credito), advertisements (Mercado Clics), classifieds, and a turnkey e-commerce solution (Mercado Shops) rounding out its arsenal. MercadoLibre generates revenue from final value fees, advertising royalties, payment processing, insertion fees, subscription fees, and interest income from consumer and small-business lending.
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.